GPx3 promoter hypermethylation is a frequent event in human cancer and is associated with tumorigenesis and chemotherapy response.

[1]  A. Berdal,et al.  Sodium fluoride influences the expression of keratins in cultured keratinocytes , 2010, Cell Biology and Toxicology.

[2]  M. Osmak,et al.  The relationship between cisplatin-induced reactive oxygen species, glutathione, and BCL-2 and resistance to cisplatin , 2010, Critical reviews in toxicology.

[3]  D. Finkelstein,et al.  Bcl2 and Human Papilloma Virus 16 as Predictors of Outcome following Concurrent Chemoradiation for Advanced Oropharyngeal Cancer , 2010, Clinical Cancer Research.

[4]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[5]  M. Tan,et al.  beta-Tubulin-II expression strongly predicts outcome in patients receiving induction chemotherapy for locally advanced squamous carcinoma of the head and neck: a companion analysis of the TAX 324 trial. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  R. Brigelius-Flohé,et al.  Glutathione peroxidases in different stages of carcinogenesis. , 2009, Biochimica et biophysica acta.

[7]  A. Sakamoto,et al.  The reciprocal relationship between heme oxygenase and nitric oxide synthase in the organs of lipopolysaccharide-treated rodents. , 2009, Biomedical research.

[8]  G. Rosner,et al.  Residual DNA methylation at remission is prognostic in adult Philadelphia chromosome-negative acute lymphocytic leukemia. , 2009, Blood.

[9]  M. Esteller,et al.  Epigenetic biomarkers for human cancer: the time is now. , 2008, Critical reviews in oncology/hematology.

[10]  M. Tan,et al.  Elevated Expression of Glutathione S-Transferase π and p53 Confers Poor Prognosis in Head and Neck Cancer Patients Treated with Chemoradiotherapy but not Radiotherapy Alone , 2008, Clinical Cancer Research.

[11]  K. Washington,et al.  DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett’s adenocarcinoma , 2008, Gut.

[12]  A. T. Lau,et al.  Reactive oxygen species: Current knowledge and applications in cancer research and therapeutic , 2008, Journal of cellular biochemistry.

[13]  지창도.  Identification of genes epigenetically silenced by CpG methylation in human gastric carcinoma , 2008 .

[14]  George Tseng,et al.  Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. , 2007, Cancer research.

[15]  U. Förstermann,et al.  Reciprocal Regulation of Endothelial Nitric-Oxide Synthase and NADPH Oxidase by Betulinic Acid in Human Endothelial Cells , 2007, Journal of Pharmacology and Experimental Therapeutics.

[16]  Guojun Wu,et al.  LOXL1 and LOXL4 are epigenetically silenced and can inhibit ras/extracellular signal-regulated kinase signaling pathway in human bladder cancer. , 2007, Cancer research.

[17]  Y. Soini,et al.  Reactive oxygen species and antioxidant mechanisms in human tissues and their relation to malignancies , 2007, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[18]  H. Nakamura,et al.  Tumor-targeted induction of oxystress for cancer therapy , 2007, Journal of drug targeting.

[19]  H. Ahsan,et al.  Reactive oxygen species: role in the development of cancer and various chronic conditions , 2006, Journal of carcinogenesis.

[20]  A. Chatterjee,et al.  Head and neck cancer cell lines exhibit differential mitochondrial repair deficiency in response to 4NQO. , 2006, Oral oncology.

[21]  S. Baylin,et al.  DNA methylation and gene silencing in cancer , 2005, Nature Clinical Practice Oncology.

[22]  C. Moskaluk,et al.  Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. , 2005, Neoplasia.

[23]  Joachim Diebold,et al.  Functional epigenomics identifies genes frequently silenced in prostate cancer. , 2005, Cancer research.

[24]  C. Dumontet,et al.  Chemoresistance in non-small cell lung cancer. , 2005, Current medicinal chemistry. Anti-cancer agents.

[25]  Christopher J. Rhodes,et al.  Role of oxygen radicals in DNA damage and cancer incidence , 2004, Molecular and Cellular Biochemistry.

[26]  S. Nomoto,et al.  Inverse Correlation between Cyclin A1 Hypermethylation and p53 Mutation in Head and Neck Cancer Identified by Reversal of Epigenetic Silencing , 2004, Cancer Research.

[27]  Teiji Wada,et al.  Mitogen-activated protein kinases in apoptosis regulation , 2004, Oncogene.

[28]  Laura E. Clark,et al.  Iron, oxidative stress, and disease risk. , 2004, Nutrition reviews.

[29]  U. Haberkorn,et al.  Tumor-specific gene expression using regulatory elements of the glucose transporter isoform 1 gene , 2004, Cancer Gene Therapy.

[30]  L. Schumaker,et al.  Glutathione S-transferase pi amplification is associated with cisplatin resistance in head and neck squamous cell carcinoma cell lines and primary tumors. , 2003, Cancer research.

[31]  L. Behrend,et al.  Reactive oxygen species in oncogenic transformation. , 2003, Biochemical Society transactions.

[32]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[33]  P. Glazer,et al.  Molecular markers in clinical radiation oncology , 2003, Oncogene.

[34]  P. Ladenson,et al.  Methylation of the thyroid-stimulating hormone receptor gene in epithelial thyroid tumors: a marker of malignancy and a cause of gene silencing. , 2003, Cancer research.

[35]  F. Zunino,et al.  Mechanisms controlling sensitivity to platinum complexes: role of p53 and DNA mismatch repair. , 2003, Current cancer drug targets.

[36]  J. Yodoi,et al.  A Comparative Study on the Hydroperoxide and Thiol Specificity of the Glutathione Peroxidase Family and Selenoprotein P* , 2002, The Journal of Biological Chemistry.

[37]  Ahmedin Jemal,et al.  Cancer Statistics, 2002 , 2002, CA: a cancer journal for clinicians.

[38]  K. Tew,et al.  Cellular thiols and reactive oxygen species in drug-induced apoptosis. , 2001, The Journal of pharmacology and experimental therapeutics.

[39]  T. Perfetti,et al.  The composition of cigarette smoke: a retrospective, with emphasis on polycyclic components , 2000, Human & experimental toxicology.

[40]  K. Conklin.  Dietary Antioxidants During Cancer Chemotherapy: Impact on Chemotherapeutic Effectiveness and Development of Side Effects , 2000, Nutrition and cancer.

[41]  G. Yang,et al.  Oxidative damage in an esophageal adenocarcinoma model with rats. , 2000, Carcinogenesis.

[42]  B. Trock,et al.  Prognostic Value of p53, Glutathione S-Transferase π, and Thymidylate Synthase for Neoadjuvant Cisplatin-based Chemotherapy in Head and Neck Cancer , 1999 .

[43]  K. Kinzler,et al.  Lessons from Hereditary Colorectal Cancer , 1996, Cell.

[44]  Jinn-Moon Yang,et al.  Free radicals and breast cancer. , 1996, Environmental health perspectives.

[45]  N. Polissar,et al.  Progression of human breast cancers to the metastatic state is linked to hydroxyl radical-induced DNA damage. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[46]  A. Fornace,et al.  Genomic instability and the role of p53 mutations in cancer cells. , 1995, Current opinion in oncology.

[47]  B. Ames,et al.  Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[48]  A. Forastiere.  Overview of platinum chemotherapy in head and neck cancer. , 1994, Seminars in oncology.

[49]  H. Joenje,et al.  Mutational specificity of oxidative DNA damage. , 1993, Mutation research.

[50]  G. Hortobagyi,et al.  Inflammatory breast cancer: a review. , 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[51]  D. C. Malins,et al.  Major alterations in the nucleotide structure of DNA in cancer of the female breast. , 1991, Cancer research.

[52]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.